SD

Sneha Dutta

Active Director Director DIN 11069017
DIN 11069017 First appointment Jun 2025 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value •••• Premium profile

About Sneha Dutta

Data last updated:

Sneha Dutta is a Director at Medality Pharma Private Limited (since 2025). The company operates in Trading. Medality Pharma Private Limited reported revenue of ₹4.22 Cr (FY 2025).

DIN 11069017
Primary Designation Director
Industry Trading
First Appointment 11 Jun 2025
Oldest Company Age 5 yrs
Largest company Medality Pharma Private Limited · ₹4.22 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medality Pharma Private Limited U51909WB2021PTC245916
Director11 Jun 20252021₹4.22 Cr (FY 2025)Active

Board colleagues of Sneha Dutta

NameDINCompanyDesignation
Pritam Singha Roy09189485Medality Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medality Pharma Private Limited
Premium access

Shareholding and investment profile for Sneha Dutta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sneha Dutta

Sneha Dutta currently holds 1 directorship: Medality Pharma Private Limited (Director, since 11 Jun 2025, revenue ₹4.22 Cr (FY 2025)).

Sneha Dutta was first appointed on 11 Jun 2025 as Director at Medality Pharma Private Limited.

The current boards of Sneha Dutta's companies include Pritam Singha Roy (Medality Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available